BioWorld Asia

April 7, 2010

Convoluted Rules, Bureaucracy Threaten UK Clinical Research

LONDON - The UK government has ordered a rapid and independent review of how clinical trials are regulated, amid evidence that complex and cumbersome rules are driving such research overseas. (BioWorld International) Read More

€33.1M Financing Gives VC Big Slice of Epigenomics

No Abstract Read More

Study of Common Copy Number Variants Ends in Disappointment

BiondVax Strives to Put an End to Annual Flu Vaccine Treadmill

Russia's Protek Seeking $400M in International Public Offering

Deinove Seeking $20M IPO to Fund Ethanol Operation

Horizon, Nitec Merger Creates a New Player in Pain Market

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for June 23, 2026.

News in brief

BioWorld Asia

BioWorld Asia briefs for June 23, 2026

Have brain-computer interfaces finally arrived?

BioWorld

More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...

Photo of two people shaking hands near lab equipment

K2 nabs two Antengene bispecific TCEs in $2B license, option deal

BioWorld

MPM Bioimpact-spawned K2 Therapeutics Inc. inked a license deal plus option agreement, worth $980.5 million apiece, to gain ex-China rights to two of Antengene...

In the clinic for June 22, 2026

BioWorld

Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...